CTNM Competitors & Alternatives
Compare Contineum Therapeutics, Inc. Class A Common Stock with similar stocks in the same industry
Biotechnology
CTNM
Main Stock$8.35
Tradestie Score
58
Market Cap
$308.74M
Analyst Upside
+165.2%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$14.89
|
$354.45M | - | 56 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$39.23
|
$353.70M | 410.0 | 38 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.44
|
$350.98M | - | 63 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.86
|
$332.96M | - | 59 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.72
|
$328.62M | - | 49 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.73
|
$307.12M | - | 61 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.37
|
$304.12M | - | 60 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$15.13
|
$297.23M | - | 50 | Compare |
|
OMER
Omeros Corporation
|
$16.26
|
$281.75M | 13.6 | 62 | Compare |
|
DBVT
DBV Technologies S.A.
|
$9.62
|
$275.54M | - | 61 | Compare |
More CTNM Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry